These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7330918)

  • 1. Tuberculin sensitivity in kala-azar.
    Rees PH; Kager PA; Muriithi MR; Wambua PP; Shah SD; Butterworth AE
    Trans R Soc Trop Med Hyg; 1981; 75(5):630-1. PubMed ID: 7330918
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculin sensitivity in kala-azar.
    Sharma VK; Jha TK
    J Indian Med Assoc; 1987 Feb; 85(2):61. PubMed ID: 3611825
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cell-mediated immunity in patients with kala-azar.
    Hepner Levy L; Mendes E
    Allergol Immunopathol (Madr); 1981; 9(2):109-12. PubMed ID: 7293874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
    el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
    Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widal reaction in Kala-azar.
    Singh UK; Sinha RK; Sharma VK
    Indian Pediatr; 1995 Jun; 32(6):680-3. PubMed ID: 8613339
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential role for interleukin-10 in the immunosuppression associated with kala azar.
    Holaday BJ; Pompeu MM; Jeronimo S; Texeira MJ; Sousa Ade A; Vasconcelos AW; Pearson RD; Abrams JS; Locksley RM
    J Clin Invest; 1993 Dec; 92(6):2626-32. PubMed ID: 8254019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of anti-leishmanial serum antibody titre in Indian kala-azar.
    Sinha AN; Srivastava SN; Gupta AK; Shrama MC; Prasad LS
    J Commun Dis; 1985; 17(1 Suppl):100-6. PubMed ID: 3913693
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visceral leishmaniasis (kala-azar)].
    Berentsen S; Langholm R; Reitan O
    Tidsskr Nor Laegeforen; 1990 Nov; 110(27):3491-3. PubMed ID: 2256078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leishmanin test and immunity in kala azar.
    MANSON-BAHR PE
    East Afr Med J; 1961 Apr; 38():165-7. PubMed ID: 13766296
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the immunology and serology of leishmaniasis. IX. Serological investigation of the parasites of Indian kala-azar and Indian post-kala-azar dermal leishmaniasis.
    Bray RS; Ashford RW; Mukherjee AM; Sen Gupta PC
    Trans R Soc Trop Med Hyg; 1973; 67(1):125-9. PubMed ID: 4777392
    [No Abstract]   [Full Text] [Related]  

  • 19. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
    Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
    Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of circulating antigens by McAb-AST for evaluation of the therapeutic effect of kala-azar cases].
    Hu XS; Lin FQ; Liu Q; Wang YJ; Luo P; Qin Z; Bao L; Yuan HS; Lan L
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):161-4. PubMed ID: 3557420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.